Profile data is unavailable for this security.
About the company
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
- Revenue in EUR (TTM)1.70bn
- Net income in EUR156.30m
- Incorporated--
- Employees7.41k
- LocationSOL SpAVia Borgazzi, 27MONZA 20900ItalyITA
- Phone+39 3923961
- Fax+39 392396265
- Websitehttps://www.sol.it/
More ▼
Mergers & acquisitions
| Acquired company | SOL:MIL since announced | Transaction value |
|---|---|---|
| Vitalaire Suisse SA | -1.96% | -- |
Data delayed at least 15 minutes, as of Feb 10 2026 08:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HEXPOL AB | 1.82bn | 182.78m | 2.34bn | 4.91k | 13.35 | 1.85 | 9.87 | 1.28 | 5.64 | 5.64 | 56.10 | 40.71 | 0.8078 | 7.48 | 7.59 | 3,935,642.00 | 8.12 | 10.68 | 11.61 | 14.81 | 21.03 | 21.15 | 10.05 | 11.52 | 0.6061 | 20.22 | 0.2361 | 68.63 | -5.45 | 7.56 | -12.48 | 6.64 | -- | 12.80 |
| K+S AG | 3.64bn | -1.70bn | 2.56bn | 11.36k | -- | 0.6058 | -- | 0.7037 | -9.49 | -9.49 | 20.32 | 23.80 | 0.4433 | 4.57 | 5.44 | 317,413.70 | -20.70 | 4.08 | -22.48 | 4.82 | 11.92 | 21.93 | -46.70 | 10.05 | 2.33 | -- | 0.1039 | 19.65 | -5.67 | 7.46 | -131.82 | -- | 0.6324 | 30.26 |
| Solvay SA | 4.91bn | 154.00m | 2.83bn | 8.67k | 18.48 | 2.32 | 5.75 | 0.5776 | 1.45 | 1.45 | 46.40 | 11.52 | 0.7628 | 6.54 | 6.77 | 565,809.20 | 2.52 | 2.59 | 3.43 | 3.40 | 21.24 | 24.79 | 3.30 | 4.20 | 1.04 | 8.61 | 0.6359 | 78.01 | -14.84 | -14.50 | 270.23 | -- | -19.76 | -8.31 |
| Clariant AG | 4.45bn | 123.78m | 3.00bn | 10.27k | 24.13 | 1.42 | 6.87 | 0.6744 | 0.3421 | 0.3421 | 12.30 | 5.82 | 0.6676 | 3.78 | 6.73 | 388,246.50 | 2.43 | 2.49 | 3.37 | 3.61 | 31.80 | 29.56 | 3.64 | 3.71 | 0.8993 | 6.67 | 0.4962 | 83.72 | -5.14 | -1.15 | 45.24 | -- | -6.28 | -32.51 |
| Kemira Oyj | 2.81bn | 219.10m | 3.14bn | 4.77k | 14.76 | 1.85 | 7.32 | 1.11 | 1.41 | 1.41 | 18.15 | 11.29 | 0.8736 | -- | 6.56 | 598,914.40 | 7.20 | 5.96 | 9.43 | 7.98 | -- | 37.45 | 8.24 | 6.44 | 1.28 | 15.37 | 0.2847 | 53.39 | -12.87 | 2.09 | 25.26 | 17.75 | -3.61 | 5.73 |
| Gubre Fabrikalari TAS | 1.02bn | 116.04m | 3.33bn | 1.89k | 28.72 | 6.30 | 22.23 | 3.28 | 18.04 | 17.70 | 158.10 | 82.26 | 1.01 | 5.98 | 9.24 | 29,228,970.00 | 11.85 | 0.4316 | 22.30 | 1.17 | 22.84 | 14.19 | 11.68 | 0.322 | 0.8961 | -- | 0.2032 | -- | -4.72 | 61.98 | 137.70 | -- | 76.38 | -- |
| Wacker Chemie AG | 5.57bn | 21.70m | 3.94bn | 16.62k | 172.56 | 0.8865 | 7.12 | 0.7081 | 0.4416 | 0.4416 | 112.17 | 85.95 | 0.6361 | 2.86 | 6.74 | 334,573.50 | 0.4308 | 7.02 | 0.5175 | 8.70 | 15.28 | 21.69 | 0.6773 | 9.28 | 1.64 | 2.84 | 0.3046 | 48.76 | -10.63 | 3.03 | -23.15 | -- | 9.44 | 37.97 |
| SOL SpA | 1.70bn | 156.30m | 4.28bn | 7.41k | 27.37 | 4.04 | 13.07 | 2.51 | 1.72 | 1.72 | 18.79 | 11.68 | 0.7896 | 3.99 | 3.36 | 233,844.90 | 7.62 | 7.88 | 9.77 | 10.18 | 74.36 | 72.78 | 9.64 | 9.86 | 2.04 | 13.82 | 0.4142 | 22.16 | 8.29 | 12.23 | 1.35 | 24.52 | 8.50 | 17.38 |
| Arkema SA | 9.24bn | 127.00m | 4.49bn | 21.15k | 35.32 | 0.6149 | 4.79 | 0.4859 | 1.67 | 1.67 | 122.00 | 95.95 | 0.638 | 5.56 | 6.80 | 438,098.80 | 0.967 | 5.29 | 1.14 | 6.36 | 18.68 | 21.18 | 1.52 | 7.06 | 2.26 | 4.38 | 0.3645 | 36.03 | 0.3153 | 1.78 | -15.92 | -7.20 | 2.86 | 10.35 |
| Johnson Matthey PLC | 13.10bn | -145.96m | 4.53bn | 10.64k | -- | 1.88 | 98.56 | 0.346 | -0.7474 | -0.7593 | 67.38 | 12.50 | 1.90 | 10.54 | 7.75 | 1,070,556.00 | -2.12 | 3.05 | -3.56 | 5.41 | 7.04 | 6.81 | -1.11 | 1.49 | 1.28 | 6.02 | 0.4153 | 65.12 | -9.10 | -4.34 | 245.37 | 7.90 | -3.38 | 6.72 |
| Croda International Plc | 1.92bn | 160.78m | 4.70bn | 6.03k | 29.24 | 1.84 | 14.60 | 2.45 | 1.00 | 1.00 | 11.93 | 15.87 | 0.4736 | 2.45 | 4.59 | 276,754.60 | 4.04 | 9.31 | 4.57 | 10.63 | 45.10 | 46.26 | 8.54 | 17.37 | 1.19 | 9.91 | 0.2485 | 47.86 | -3.92 | 3.40 | -7.31 | -6.68 | 10.37 | 4.10 |
| Umicore SA | 16.10bn | 128.82m | 4.92bn | 11.41k | 37.15 | 2.35 | 11.26 | 0.3055 | 0.5372 | 0.5372 | 67.06 | 8.50 | 1.91 | 6.38 | 12.70 | 1,390,302.00 | 1.72 | 0.3984 | 2.99 | 0.6666 | 7.76 | 6.54 | 0.897 | 0.1755 | 0.7247 | 2.34 | 0.5876 | 273.74 | -18.68 | -3.21 | -484.31 | -- | -0.1916 | 5.92 |
| Imcd NV | 4.82bn | 266.69m | 5.09bn | 5.28k | 18.79 | 2.57 | 12.51 | 1.06 | 4.58 | 4.58 | 82.65 | 33.46 | 1.06 | 5.34 | 5.26 | 939,651.80 | 5.85 | 7.00 | 7.89 | 9.40 | 22.48 | 21.91 | 5.54 | 6.06 | 1.04 | 4.72 | 0.4671 | 44.62 | 6.41 | 11.94 | -4.80 | 20.84 | 8.34 | 19.03 |
Data as of Feb 10 2026. Currency figures normalised to SOL SpA's reporting currency: Euro EUR
17.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| J.O. Hambro Capital Management Ltd.as of 14 May 2025 | 4.46m | 4.91% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2025 | 3.33m | 3.68% |
| Tweedy, Browne Co. LLCas of 27 May 2025 | 2.65m | 2.92% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.40m | 1.54% |
| Norges Bank Investment Managementas of 14 May 2025 | 1.23m | 1.35% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 565.03k | 0.62% |
| Eurizon Capital SGR SpAas of 28 Nov 2025 | 559.23k | 0.62% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 551.42k | 0.61% |
| Amundi SGR SpAas of 28 Nov 2025 | 515.10k | 0.57% |
| Degroof Petercam Asset Management SAas of 31 Oct 2025 | 497.53k | 0.55% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
